[go: up one dir, main page]

HK40059367A - Compositions for the treatment of disease with immune stimulatory conjugates - Google Patents

Compositions for the treatment of disease with immune stimulatory conjugates Download PDF

Info

Publication number
HK40059367A
HK40059367A HK62022046750.5A HK62022046750A HK40059367A HK 40059367 A HK40059367 A HK 40059367A HK 62022046750 A HK62022046750 A HK 62022046750A HK 40059367 A HK40059367 A HK 40059367A
Authority
HK
Hong Kong
Prior art keywords
disease
compositions
treatment
immune stimulatory
stimulatory conjugates
Prior art date
Application number
HK62022046750.5A
Other languages
Chinese (zh)
Inventor
Valerie Odegard
Peter Baum
Sean Wesley Smith
Craig Alan Coburn
Peter Armstrong Thompson
Original Assignee
Silverback Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Silverback Therapeutics, Inc. filed Critical Silverback Therapeutics, Inc.
Publication of HK40059367A publication Critical patent/HK40059367A/en

Links

HK62022046750.5A 2018-09-12 2019-09-11 Compositions for the treatment of disease with immune stimulatory conjugates HK40059367A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862730499P 2018-09-12
US201962810816P 2019-02-26
US201962816992P 2019-03-12

Publications (1)

Publication Number Publication Date
HK40059367A true HK40059367A (en) 2022-05-06

Family

ID=

Similar Documents

Publication Publication Date Title
IL281210A (en) Compositions for the treatment of disease with immune stimulatory conjugates
SG11202000944SA (en) Cytokine conjugates for the treatment of autoimmune diseases
EP3448874A4 (en) Compositions for the treatment of disease
EP3448987A4 (en) Compositions for the treatment of disease
EP3880239A4 (en) THERAPEUTIC SIRPalpha ANTIBODIES
IL276043A (en) Process for the preparation of galnac oligonucleotide conjugates
GB202020354D0 (en) Compositions for the treatment of disease with immune stimulatory conjugates
EP3813872A4 (en) Compositions for the treatment of skin conditions
EP3752163A4 (en) Promoting immune responses
PL3710011T3 (en) Pentacyclic triterpenes for the treatment of an oral disease
HK40059367A (en) Compositions for the treatment of disease with immune stimulatory conjugates
EP3634395A4 (en) Formulations of lixivaptan for the treatment of polycystic disease
HK40060055A (en) Treatment with highly silylated igg compositions
HK40031473A (en) Cytokine conjugates for the treatment of autoimmune diseases
HK40127919A (en) Vaccine composition
HK40078426A (en) Immune stimulating micelle composition
HK40060325A (en) Therapeutic sirpalpha antibodies
HK40053739A (en) Immune modifying particles for the treatment of cancer
HK40038582A (en) Antibody construct-drug conjugate for the treatment of hepatitis
HK40049572A (en) Immunogenic compositions
HK40031578A (en) Methods and compositions for the treatment of diseases associated with cancer, inflammation, or immune response
HK40070694A (en) Hantavirus antigenic composition
HK40045587A (en) Compositions for the treatment of graft versus host disease
EP3876919A4 (en) Compositions for the treatment of cancer and other conditions
HK40051044A (en) Anti-fgfr2 antibody formulations